U.S. Medicine, a leading publication for federal healthcare professionals, has featured bioAffinity Technologies’ CyPath® Lung in its pulmonary issue, highlighting the test’s potential to improve lung ...

Abstract: The persistent threat that lung cancer poses to people's health emphasizes the urgent requirement for cuttingedge detection technology. This work offers a novel approach for diagnosing and ...

ABSTRACT: Lung cancer stands as the preeminent cause of cancer-related mortality globally. Prompt and precise diagnosis, coupled with effective treatment, is imperative to reduce the fatality rates ...

ABSTRACT: Lung cancer stands as the preeminent cause of cancer-related mortality globally. Prompt and precise diagnosis, coupled with effective treatment, is imperative to reduce the fatality rates ...

Please provide your email address to receive an email when new articles are posted on . The number of lung cancer cases was greater in the highest vs. lowest group of energy-adjusted ultra-processed ...

A promising new study has identified a highly accurate, non-invasive method to diagnose non-small cell lung cancer (NSCLC) using a blood test based on tRNA signatures. NSCLC accounts for roughly 85% ...

You can create a release to package software, along with release notes and links to binary files, for other people to use. Learn more about releases in our docs.

As we age, our cells replicate, and the DNA in these cells can acquire mistakes—or mutations—every time the sequence is copied. Most newly acquired mutations are harmless, but some can tip the balance ...

The gut microbiome has emerged as a key modulator of immune responses and treatment efficacy in oncology. Growing evidence links gut dysbiosis to resistance against immune checkpoint inhibitors (ICIs) ...